Diabetic iris neovascularization. Natural history and treatment
- PMID: 9088410
- DOI: 10.1111/j.1600-0420.1997.tb00258.x
Diabetic iris neovascularization. Natural history and treatment
Abstract
Purpose: To study the spontaneous progression from iris neovascularization to neovascular glaucoma, factors that determine how long it takes and the efficacy of therapy, we studied 81 eyes belonging to 67 diabetic patients.
Methods: The eyes were divided into three groups: control group (29 eyes, 26 patients), photocoagulation group (37 eyes, 30 patients) and cryotherapy group (15 eyes, 11 patients). The controls were observed for at least 12 months, and the treated group over at least the following 3 months.
Results: At the end of the follow-up period 12 of the 29 control group eyes (41.4%) had developed neovascular glaucoma and 6 (20.5%) increased neovascularization. Seven eyes (58%) that developed glaucoma did so within 3 months. There was no significant difference between the laser therapy (improvement: 84%) and cryotherapy group (80.5%).
Conclusions: At the end of the 12-month follow-up period progression from iris neovascularization to neovascular glaucoma is very frequent. There was no difference between laser therapy and cryotherapy.
Similar articles
-
Iris neovascularization and neovascular glaucoma in neurofibromatosis type 1: report of 3 cases in children.J Glaucoma. 2013 Apr-May;22(4):336-41. doi: 10.1097/IJG.0b013e318239c35d. J Glaucoma. 2013. PMID: 22138687
-
Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28. Ophthalmology. 2008. PMID: 18440643
-
[Photocoagulation in diabetic rubeosis iridis and neovascular glaucoma].Klin Monbl Augenheilkd. 1987 Jan;190(1):11-6. doi: 10.1055/s-2008-1050319. Klin Monbl Augenheilkd. 1987. PMID: 2437355 German.
-
Angiogenesis in glaucoma filtration surgery and neovascular glaucoma: A review.Surv Ophthalmol. 2015 Nov-Dec;60(6):524-35. doi: 10.1016/j.survophthal.2015.04.003. Epub 2015 May 15. Surv Ophthalmol. 2015. PMID: 25980779 Free PMC article. Review.
-
[Diabetic neovascularisation and secondary glaucoma].Orv Hetil. 2011 Jul 17;152(29):1167-70. doi: 10.1556/OH.2011.29042. Orv Hetil. 2011. PMID: 21712182 Review. Hungarian.
Cited by
-
Rapid improvement of retinal and iris neovascularization after a single intravitreal bevacizumab injection in a patient with central retinal vein occlusion and neovascular glaucoma.Int Ophthalmol. 2008 Feb;28(1):59-61. doi: 10.1007/s10792-007-9105-2. Epub 2007 Jul 4. Int Ophthalmol. 2008. PMID: 17609852
-
A Review of Neovascular Glaucoma: Etiology, Pathogenesis, Diagnosis, and Treatment.Medicina (Kaunas). 2022 Dec 18;58(12):1870. doi: 10.3390/medicina58121870. Medicina (Kaunas). 2022. PMID: 36557072 Free PMC article. Review.
-
Neovascular glaucoma: a review.Int J Retina Vitreous. 2016 Nov 14;2:26. doi: 10.1186/s40942-016-0051-x. eCollection 2016. Int J Retina Vitreous. 2016. PMID: 27895936 Free PMC article. Review.
-
Intravitreal bevacizumab treatment for neovascular glaucoma: histopathological analysis of trabeculectomy specimens.Graefes Arch Clin Exp Ophthalmol. 2011 Oct;249(10):1547-52. doi: 10.1007/s00417-011-1761-2. Epub 2011 Aug 13. Graefes Arch Clin Exp Ophthalmol. 2011. PMID: 21842129
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical